Annual EBIT
-$800.66 M
+$3.87 B+82.84%
31 December 2023
Summary:
Bio-Rad Laboratories annual earnings before interest & taxes is currently -$800.66 million, with the most recent change of +$3.87 billion (+82.84%) on 31 December 2023. During the last 3 years, it has fallen by -$5.74 billion (-116.21%). BIO annual EBIT is now -114.69% below its all-time high of $5.59 billion.BIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$873.79 M
+$3.65 B+131.50%
30 September 2024
Summary:
Bio-Rad Laboratories quarterly earnings before interest & taxes is currently $873.79 million, with the most recent change of +$3.65 billion (+131.50%) on 30 September 2024. Over the past year, it has increased by +$724.29 million (+484.48%). BIO quarterly EBIT is now -82.60% below its all-time high of $5.02 billion, reached on 30 September 2021.BIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$956.12 M
+$724.29 M+43.10%
30 September 2024
Summary:
Bio-Rad Laboratories TTM earnings before interest & taxes is currently -$956.12 million, with the most recent change of +$724.29 million (+43.10%) on 30 September 2024. Over the past year, it has dropped by -$817.66 million (-590.57%). BIO TTM EBIT is now -111.15% below its all-time high of $8.57 billion, reached on 30 September 2021.BIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +82.8% | +484.5% | -590.6% |
| 3 y3 years | -116.2% | -82.6% | -111.2% |
| 5 y5 years | -249.2% | +365.0% | -275.8% |
BIO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -114.7% | +82.8% | -82.6% | +120.0% | -111.2% | +87.7% |
| 5 y | 5 years | -114.7% | +82.8% | -82.6% | +120.0% | -111.2% | +87.7% |
| alltime | all time | -114.7% | +82.8% | -82.6% | +120.0% | -111.2% | +87.7% |
Bio-Rad Laboratories EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $873.79 M(-131.5%) | -$956.12 M(-43.1%) |
| June 2024 | - | -$2.77 B(-651.1%) | -$1.68 B(+326.0%) |
| Mar 2024 | - | $503.36 M(+14.2%) | -$394.48 M(-50.7%) |
| Dec 2023 | -$800.66 M(-82.8%) | $440.75 M(+194.8%) | -$800.66 M(+478.3%) |
| Sept 2023 | - | $149.50 M(-110.0%) | -$138.45 M(-71.4%) |
| June 2023 | - | -$1.49 B(-1631.5%) | -$483.61 M(+135.9%) |
| Mar 2023 | - | $97.17 M(-91.2%) | -$205.01 M(-95.6%) |
| Dec 2022 | -$4.67 B(-185.6%) | $1.10 B(-663.7%) | -$4.67 B(-40.1%) |
| Sept 2022 | - | -$195.66 M(-83.8%) | -$7.80 B(+202.5%) |
| June 2022 | - | -$1.21 B(-72.3%) | -$2.58 B(+1123.3%) |
| Mar 2022 | - | -$4.36 B(+115.3%) | -$210.68 M(-103.9%) |
| Dec 2021 | $5.45 B(+10.3%) | -$2.03 B(-140.4%) | $5.45 B(-36.4%) |
| Sept 2021 | - | $5.02 B(+334.1%) | $8.57 B(+63.6%) |
| June 2021 | - | $1.16 B(-10.8%) | $5.24 B(-1.8%) |
| Mar 2021 | - | $1.30 B(+18.7%) | $5.33 B(+8.0%) |
| Dec 2020 | $4.94 B(+116.2%) | $1.09 B(-35.3%) | $4.94 B(+8.5%) |
| Sept 2020 | - | $1.69 B(+35.0%) | $4.55 B(+79.8%) |
| June 2020 | - | $1.25 B(+38.4%) | $2.53 B(+23.2%) |
| Mar 2020 | - | $904.39 M(+28.2%) | $2.06 B(-10.0%) |
| Dec 2019 | $2.28 B(+325.7%) | $705.49 M(-314.0%) | $2.28 B(+320.0%) |
| Sept 2019 | - | -$329.69 M(-142.5%) | $543.89 M(-55.8%) |
| June 2019 | - | $775.44 M(-31.6%) | $1.23 B(+53.6%) |
| Mar 2019 | - | $1.13 B(-209.5%) | $800.40 M(+49.2%) |
| Dec 2018 | $536.62 M(+344.2%) | -$1.04 B(-390.6%) | $536.62 M(-66.9%) |
| Sept 2018 | - | $356.19 M(+2.9%) | $1.62 B(+24.5%) |
| June 2018 | - | $346.06 M(-60.2%) | $1.30 B(+35.1%) |
| Mar 2018 | - | $869.47 M(+1580.8%) | $964.83 M(+698.6%) |
| Dec 2017 | $120.82 M(+86.0%) | $51.73 M(+41.9%) | $120.82 M(+154.7%) |
| Sept 2017 | - | $36.46 M(+408.9%) | $47.44 M(+20.7%) |
| June 2017 | - | $7.17 M(-71.9%) | $39.30 M(-39.2%) |
| Mar 2017 | - | $25.46 M(-217.6%) | $64.63 M(-0.5%) |
| Dec 2016 | $64.94 M(-61.2%) | -$21.65 M(-176.5%) | $64.94 M(-55.8%) |
| Sept 2016 | - | $28.32 M(-12.8%) | $146.82 M(-1.9%) |
| June 2016 | - | $32.50 M(+26.1%) | $149.74 M(-7.3%) |
| Mar 2016 | - | $25.77 M(-57.2%) | $161.62 M(-3.5%) |
| Dec 2015 | $167.54 M(+9.0%) | $60.23 M(+92.8%) | $167.54 M(+6.0%) |
| Sept 2015 | - | $31.24 M(-29.6%) | $158.05 M(+0.7%) |
| June 2015 | - | $44.37 M(+40.0%) | $157.00 M(-6.0%) |
| Mar 2015 | - | $31.70 M(-37.5%) | $166.99 M(+8.7%) |
| Dec 2014 | $153.69 M(-11.5%) | $50.75 M(+68.1%) | $153.69 M(-0.5%) |
| Sept 2014 | - | $30.19 M(-44.5%) | $154.47 M(+2.5%) |
| June 2014 | - | $54.36 M(+195.5%) | $150.68 M(-4.0%) |
| Mar 2014 | - | $18.39 M(-64.3%) | $157.03 M(-9.6%) |
| Dec 2013 | $173.66 M(-38.2%) | $51.53 M(+95.2%) | $173.66 M(-10.9%) |
| Sept 2013 | - | $26.39 M(-56.5%) | $194.90 M(-17.2%) |
| June 2013 | - | $60.71 M(+73.3%) | $235.41 M(-7.0%) |
| Mar 2013 | - | $35.02 M(-51.9%) | $253.12 M(-8.8%) |
| Dec 2012 | $281.02 M(-6.0%) | $72.77 M(+8.8%) | $277.47 M(-7.7%) |
| Sept 2012 | - | $66.90 M(-14.7%) | $300.68 M(-0.4%) |
| June 2012 | - | $78.42 M(+32.1%) | $301.89 M(+2.9%) |
| Mar 2012 | - | $59.38 M(-38.1%) | $293.33 M(-1.9%) |
| Dec 2011 | $298.98 M(+5.3%) | $95.98 M(+40.9%) | $298.98 M(+6.5%) |
| Sept 2011 | - | $68.11 M(-2.5%) | $280.75 M(-1.5%) |
| June 2011 | - | $69.86 M(+7.4%) | $284.94 M(+0.1%) |
| Mar 2011 | - | $65.03 M(-16.4%) | $284.76 M(+0.3%) |
| Dec 2010 | $284.00 M(+22.0%) | $77.75 M(+7.5%) | $284.00 M(+8.1%) |
| Sept 2010 | - | $72.31 M(+3.8%) | $262.71 M(+2.6%) |
| June 2010 | - | $69.68 M(+8.4%) | $256.11 M(+4.1%) |
| Mar 2010 | - | $64.26 M(+13.8%) | $246.07 M(+5.7%) |
| Dec 2009 | $232.86 M(+33.1%) | $56.46 M(-14.1%) | $232.86 M(+23.6%) |
| Sept 2009 | - | $65.71 M(+10.2%) | $188.44 M(+8.1%) |
| June 2009 | - | $59.64 M(+16.8%) | $174.36 M(-2.4%) |
| Mar 2009 | - | $51.05 M(+323.9%) | $178.67 M(+2.1%) |
| Dec 2008 | $174.96 M(+14.8%) | $12.04 M(-76.7%) | $174.96 M(-13.9%) |
| Sept 2008 | - | $51.63 M(-19.3%) | $203.30 M(+7.5%) |
| June 2008 | - | $63.95 M(+35.1%) | $189.20 M(+17.6%) |
| Mar 2008 | - | $47.34 M(+17.2%) | $160.94 M(+5.6%) |
| Dec 2007 | $152.45 M(-12.4%) | $40.39 M(+7.6%) | $152.45 M(-8.0%) |
| Sept 2007 | - | $37.52 M(+5.2%) | $165.67 M(+4.9%) |
| June 2007 | - | $35.69 M(-8.1%) | $157.99 M(-4.6%) |
| Mar 2007 | - | $38.85 M(-27.5%) | $165.53 M(-4.9%) |
| Dec 2006 | $174.05 M(+51.0%) | $53.61 M(+79.6%) | $174.05 M(+22.3%) |
| Sept 2006 | - | $29.85 M(-30.9%) | $142.33 M(+3.2%) |
| June 2006 | - | $43.23 M(-8.7%) | $137.88 M(+12.5%) |
| Mar 2006 | - | $47.37 M(+116.4%) | $122.58 M(+6.3%) |
| Dec 2005 | $115.30 M(-6.6%) | $21.89 M(-13.8%) | $115.30 M(-3.1%) |
| Sept 2005 | - | $25.40 M(-9.0%) | $119.03 M(-0.5%) |
| June 2005 | - | $27.92 M(-30.3%) | $119.68 M(-4.8%) |
| Mar 2005 | - | $40.09 M(+56.4%) | $125.68 M(+1.8%) |
| Dec 2004 | $123.47 M | $25.63 M(-1.6%) | $123.47 M(-5.5%) |
| Sept 2004 | - | $26.05 M(-23.2%) | $130.66 M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $33.92 M(-10.4%) | $138.36 M(-1.6%) |
| Mar 2004 | - | $37.87 M(+15.4%) | $140.56 M(-4.3%) |
| Dec 2003 | $147.43 M(+6.7%) | $32.81 M(-2.8%) | $146.85 M(-0.9%) |
| Sept 2003 | - | $33.75 M(-6.6%) | $148.26 M(-1.2%) |
| June 2003 | - | $36.12 M(-18.2%) | $150.13 M(+2.1%) |
| Mar 2003 | - | $44.17 M(+29.1%) | $146.99 M(+6.3%) |
| Dec 2002 | $138.19 M(+23.4%) | $34.22 M(-3.9%) | $138.27 M(-0.2%) |
| Sept 2002 | - | $35.62 M(+8.0%) | $138.49 M(+12.2%) |
| June 2002 | - | $32.98 M(-6.9%) | $123.43 M(+5.4%) |
| Mar 2002 | - | $35.44 M(+2.9%) | $117.14 M(-4.2%) |
| Dec 2001 | $112.03 M(+67.8%) | $34.45 M(+67.6%) | $122.33 M(+19.0%) |
| Sept 2001 | - | $20.56 M(-23.0%) | $102.79 M(+5.5%) |
| June 2001 | - | $26.70 M(-34.3%) | $97.47 M(+9.5%) |
| Mar 2001 | - | $40.63 M(+172.6%) | $89.02 M(+14.9%) |
| Dec 2000 | $66.77 M(+37.4%) | $14.90 M(-2.2%) | $77.45 M(+3.5%) |
| Sept 2000 | - | $15.24 M(-16.5%) | $74.85 M(+12.4%) |
| June 2000 | - | $18.25 M(-37.2%) | $66.61 M(+9.5%) |
| Mar 2000 | - | $29.07 M(+136.3%) | $60.86 M(+25.4%) |
| Dec 1999 | $48.60 M(+56.0%) | $12.30 M(+75.7%) | $48.53 M(+7.4%) |
| Sept 1999 | - | $7.00 M(-44.0%) | $45.18 M(+11.3%) |
| June 1999 | - | $12.49 M(-25.4%) | $40.58 M(+16.3%) |
| Mar 1999 | - | $16.74 M(+87.1%) | $34.88 M(+11.6%) |
| Dec 1998 | $31.14 M(+17.1%) | $8.95 M(+272.7%) | $31.25 M(+14.0%) |
| Sept 1998 | - | $2.40 M(-64.7%) | $27.40 M(-5.2%) |
| June 1998 | - | $6.80 M(-48.1%) | $28.90 M(-1.0%) |
| Mar 1998 | - | $13.10 M(+156.9%) | $29.20 M(+9.0%) |
| Dec 1997 | $26.60 M(-31.8%) | $5.10 M(+30.8%) | $26.80 M(-4.3%) |
| Sept 1997 | - | $3.90 M(-45.1%) | $28.00 M(-15.2%) |
| June 1997 | - | $7.10 M(-33.6%) | $33.00 M(-8.1%) |
| Mar 1997 | - | $10.70 M(+69.8%) | $35.90 M(-8.7%) |
| Dec 1996 | $39.00 M(-1.8%) | $6.30 M(-29.2%) | $39.30 M(-8.0%) |
| Sept 1996 | - | $8.90 M(-11.0%) | $42.70 M(+1.9%) |
| June 1996 | - | $10.00 M(-29.1%) | $41.90 M(+2.2%) |
| Mar 1996 | - | $14.10 M(+45.4%) | $41.00 M(+3.5%) |
| Dec 1995 | $39.70 M(+8.2%) | $9.70 M(+19.8%) | $39.60 M(+1.5%) |
| Sept 1995 | - | $8.10 M(-11.0%) | $39.00 M(+2.1%) |
| June 1995 | - | $9.10 M(-28.3%) | $38.20 M(+0.3%) |
| Mar 1995 | - | $12.70 M(+39.6%) | $38.10 M(+3.8%) |
| Dec 1994 | $36.70 M(+252.9%) | $9.10 M(+24.7%) | $36.70 M(+29.2%) |
| Sept 1994 | - | $7.30 M(-18.9%) | $28.40 M(+24.0%) |
| June 1994 | - | $9.00 M(-20.4%) | $22.90 M(+38.0%) |
| Mar 1994 | - | $11.30 M(+1312.5%) | $16.60 M(+61.2%) |
| Dec 1993 | $10.40 M(-28.3%) | $800.00 K(-55.6%) | $10.30 M(-27.0%) |
| Sept 1993 | - | $1.80 M(-33.3%) | $14.10 M(-9.0%) |
| June 1993 | - | $2.70 M(-46.0%) | $15.50 M(+59.8%) |
| Mar 1993 | - | $5.00 M(+8.7%) | $9.70 M(-33.6%) |
| Dec 1992 | $14.50 M(-34.4%) | $4.60 M(+43.8%) | $14.60 M(+6.6%) |
| Sept 1992 | - | $3.20 M(-203.2%) | $13.70 M(-12.7%) |
| June 1992 | - | -$3.10 M(-131.3%) | $15.70 M(-33.8%) |
| Mar 1992 | - | $9.90 M(+167.6%) | $23.70 M(+7.2%) |
| Dec 1991 | $22.10 M(-9.4%) | $3.70 M(-28.8%) | $22.10 M(-16.6%) |
| Sept 1991 | - | $5.20 M(+6.1%) | $26.50 M(+3.9%) |
| June 1991 | - | $4.90 M(-41.0%) | $25.50 M(-0.4%) |
| Mar 1991 | - | $8.30 M(+2.5%) | $25.60 M(+4.9%) |
| Dec 1990 | $24.40 M(+15.6%) | $8.10 M(+92.9%) | $24.40 M(+16.7%) |
| Sept 1990 | - | $4.20 M(-16.0%) | $20.90 M(+2.5%) |
| June 1990 | - | $5.00 M(-29.6%) | $20.40 M(-4.2%) |
| Mar 1990 | - | $7.10 M(+54.3%) | $21.30 M(-69.8%) |
| Dec 1989 | $21.10 M(+6.6%) | $4.60 M(+24.3%) | $70.50 M(-217.7%) |
| Sept 1989 | - | $3.70 M(-37.3%) | -$59.90 M(+244.3%) |
| June 1989 | - | $5.90 M(-89.5%) | -$17.40 M(-167.7%) |
| Mar 1989 | - | $56.30 M(-144.8%) | $25.70 M(+29.1%) |
| Dec 1988 | $19.80 M(+20.7%) | -$125.80 M(-372.3%) | $19.90 M(-57.4%) |
| Sept 1988 | - | $46.20 M(-5.7%) | $46.70 M(+18.2%) |
| June 1988 | - | $49.00 M(-3.0%) | $39.50 M(+34.4%) |
| Mar 1988 | - | $50.50 M(-151.0%) | $29.40 M(+79.3%) |
| Dec 1987 | $16.40 M(+37.8%) | -$99.00 M(-353.8%) | $16.40 M(-52.7%) |
| Sept 1987 | - | $39.00 M(+0.3%) | $34.70 M(+29.5%) |
| June 1987 | - | $38.90 M(+3.7%) | $26.80 M(+38.9%) |
| Mar 1987 | - | $37.50 M(-146.5%) | $19.30 M(+63.6%) |
| Dec 1986 | $11.90 M(+36.8%) | -$80.70 M(-359.5%) | $11.80 M(-54.8%) |
| Sept 1986 | - | $31.10 M(-1.0%) | $26.10 M(+27.9%) |
| June 1986 | - | $31.40 M(+4.7%) | $20.40 M(+47.8%) |
| Mar 1986 | - | $30.00 M(-145.2%) | $13.80 M(+60.5%) |
| Dec 1985 | $8.70 M(+141.7%) | -$66.40 M(-361.4%) | $8.60 M(-51.1%) |
| Sept 1985 | - | $25.40 M(+2.4%) | $17.60 M(+43.1%) |
| June 1985 | - | $24.80 M(0.0%) | $12.30 M(+55.7%) |
| Mar 1985 | - | $24.80 M(-143.2%) | $7.90 M(+119.4%) |
| Dec 1984 | $3.60 M | -$57.40 M(-385.6%) | $3.60 M(-94.1%) |
| Sept 1984 | - | $20.10 M(-1.5%) | $61.00 M(+49.1%) |
| June 1984 | - | $20.40 M(-0.5%) | $40.90 M(+99.5%) |
| Mar 1984 | - | $20.50 M | $20.50 M |
FAQ
- What is Bio-Rad Laboratories annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual EBIT year-on-year change?
- What is Bio-Rad Laboratories quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly EBIT year-on-year change?
- What is Bio-Rad Laboratories TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM EBIT year-on-year change?
What is Bio-Rad Laboratories annual earnings before interest & taxes?
The current annual EBIT of BIO is -$800.66 M
What is the all time high annual EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual earnings before interest & taxes is $5.59 B
What is Bio-Rad Laboratories annual EBIT year-on-year change?
Over the past year, BIO annual earnings before interest & taxes has changed by +$3.87 B (+82.84%)
What is Bio-Rad Laboratories quarterly earnings before interest & taxes?
The current quarterly EBIT of BIO is $873.79 M
What is the all time high quarterly EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly earnings before interest & taxes is $5.02 B
What is Bio-Rad Laboratories quarterly EBIT year-on-year change?
Over the past year, BIO quarterly earnings before interest & taxes has changed by +$724.29 M (+484.48%)
What is Bio-Rad Laboratories TTM earnings before interest & taxes?
The current TTM EBIT of BIO is -$956.12 M
What is the all time high TTM EBIT for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM earnings before interest & taxes is $8.57 B
What is Bio-Rad Laboratories TTM EBIT year-on-year change?
Over the past year, BIO TTM earnings before interest & taxes has changed by -$817.66 M (-590.57%)